Biomarkers in Duchenne and Becker muscular dystrophy

Read full text Summarise with VIRAT
Authors: Nienke M. van de Velde
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The overall aim of this thesis was to improve and facilitate trial design for Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) by studying different types of biomarkers. To this end, the national registry for dystrophinopathy patients in the Netherlands was restructured to better support recruitment of investigator-initiated studies and pharmaceutical trials, and enable post-marketing surveillance. Next, three types of biomarkers (physiological, cardiac ultrasound and muscle MRI) and a biomarker group (circulating) were investigated for different types of context in DMD and BMD. We conclude that future research in BMD should focus finding composite surrogate endpoints (cardiac and skeletal muscle function), as well as the creation of prediction models that include several types of biomarkers.

Fields of Study & Subjects

Muscle Physiology and Disorders Neurogenetic and Muscular Disorders Research Statistical Methods in Clinical Trials

Publication details

Journal / source
Leiden Repository (Leiden University)
Publication date
26 March 2026
Language
EN
Document type
Thesis